Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lincoln Pharmaceuticals ltd. Board/Management Information 2020

Feb 24, 2020

61247_rns_2020-02-24_82819186-b509-484d-9ee5-06c2154ca309.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [112 x 115] intentionally omitted <==

Date: February 24, 2020

Date: February 24, 2020
ToThe Manager,Listing Department,National Stock Exchange of India Limited, (NSE)Exchange Plaza, C‐1, Block‐G, Bandra ‐ Kurla Complex,Bandra (E),Mumbai‐400 051. ToThe Department of Corporate Service,BSE Limited, (BSE)Phiroze Jeejeebhoy Tower,Dalal Street, Mumbai – 400 001.
Scrip Code ‐ LINCOLN Scrip Code‐531633

Dear Sir / Madam,

Sub.: Intimation of Board Meeting.

Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and any other applicable SEBI Regulations, we wish to inform you that a meeting of Board of Directors of the Company will be held on Thursday, February 27, 2020 at the Registered Office of the Company inter‐alia to consider followings:

  1. To Consider and Declare Interim Dividend to the Equity shareholders for the Financial Year 2019‐2020.

  2. The Interim Dividend, if declared, shall be paid to the Equity Shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Friday, March 06, 2020 , which is the Record Date fixed for the purpose.

  3. Any other business with the permission of the Chairman, if any.

Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, and the Company's Code of Conduct for Prevention of Insider Trading, it is hereby informed that the Trading Window for dealing in the Company's Securities shall remain closed from February 24, 2020 and shall reopen after the expiry of 48 hours from the conclusion of Board Meeting for Designated Persons viz. Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons.

==> picture [334 x 13] intentionally omitted <==

Kindly take the same on record.

==> picture [334 x 14] intentionally omitted <==

Thanking you,

==> picture [334 x 13] intentionally omitted <==

==> picture [334 x 13] intentionally omitted <==

Yours faithfully, For Lincoln Pharmaceuticals Limited MAHEND Digitally signed by MAHENDRABHAI G RABHAI G PATEL Date: 2020.02.24 PATEL 15:21:34 +05'30' ________________________ Mahendra G. Patel Managing Director DIN: 00104706

==> picture [498 x 55] intentionally omitted <==